Jie Ding Selected Research

Messenger RNA (mRNA)

1/2022	The Diagnostic Potential of SHOX2 and RASSF1A DNA Methylation in Early Lung Adenocarcinoma.
11/2021	Author Correction: mRNA analysis identifies deep intronic variants causing Alport syndrome and overcomes the problem of negative results of exome sequencing.
10/2021	mRNA analysis identifies deep intronic variants causing Alport syndrome and overcomes the problem of negative results of exome sequencing.
9/2020	Inhibition of formyl peptide receptor 1 activity suppresses tumorigenicity in vivo and attenuates the invasion and migration of lung adenocarcinoma cells under hypoxic conditions in vitro.
7/2020	Anti-angiogenic effect of a chemically sulfated polysaccharide from Phellinus ribis by inhibiting VEGF/VEGFR pathway.
1/2020	The GID ubiquitin ligase complex is a regulator of AMPK activity and organismal lifespan.
10/2019	Dissecting Molecular Mechanisms Underlying Pulmonary Vascular Smooth Muscle Cell Dedifferentiation in Pulmonary Hypertension: Role of Mutated Caveolin-1 (Cav1F92A)-Bone Marrow Mesenchymal Stem Cells.
6/2018	Phosphoglycerate mutase 1 is highly expressed in C6 glioma cells and human astrocytoma.
12/2017	MicroRNA-433 inhibits cervical cancer progression by directly targeting metadherin to regulate the AKT and β-catenin signalling pathways.
12/2017	Accelerated podocyte detachment and progressive podocyte loss from glomeruli with age in Alport Syndrome.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jie Ding Research Topics

Disease

136	Neoplasms (Cancer) 10/2022 - 03/2002
42	Inflammation (Inflammations) 01/2023 - 01/2009
42	Stomach Neoplasms (Stomach Cancer) 08/2022 - 02/2002
31	Neoplasm Metastasis (Metastasis) 10/2022 - 07/2005
27	Hepatocellular Carcinoma (Hepatoma) 10/2022 - 08/2008
25	Hereditary Nephritis (Alport Syndrome) 11/2021 - 04/2004
24	Proteinuria 05/2022 - 04/2004
23	Wounds and Injuries (Trauma) 01/2022 - 12/2006
18	Fibrosis (Cirrhosis) 01/2022 - 04/2002
17	Cicatrix (Scar) 01/2023 - 11/2009
17	Breast Neoplasms (Breast Cancer) 10/2021 - 01/2012
14	Carcinogenesis 10/2022 - 12/2004
14	Hypoxia (Hypoxemia) 01/2022 - 12/2011
13	Stroke (Strokes) 01/2022 - 02/2011
11	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 09/2015
10	Nephrotic Syndrome (Syndrome, Nephrotic) 01/2022 - 09/2003
10	Hypertrophic Cicatrix (Hypertrophic Scar) 01/2022 - 05/2011
10	Myocardial Infarction 01/2022 - 11/2017
10	Lung Neoplasms (Lung Cancer) 01/2022 - 01/2011
10	Infections 01/2022 - 06/2008
9	Burns 01/2022 - 09/2011
9	Colonic Neoplasms (Colon Cancer) 12/2021 - 01/2012
9	Carcinoma (Carcinomatosis) 04/2020 - 06/2003
8	Hypertension (High Blood Pressure) 11/2022 - 02/2014
8	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2021 - 06/2015
8	Ischemic Stroke 01/2021 - 01/2014
8	Chronic Kidney Failure (Chronic Renal Failure) 01/2020 - 11/2005
7	Prostatic Neoplasms (Prostate Cancer) 05/2022 - 01/2016
7	Neuromyelitis Optica (Devic's Disease) 01/2021 - 01/2018
6	Glioma (Gliomas) 10/2022 - 01/2016
6	Adenoma (Adenomas) 08/2022 - 01/2019
6	Necrosis 01/2022 - 12/2011
6	Kidney Diseases (Kidney Disease) 01/2019 - 10/2010
5	Body Weight (Weight, Body) 06/2022 - 04/2015
5	Type 2 Diabetes Mellitus (MODY) 10/2021 - 11/2010
5	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2021 - 08/2010
5	Thrombosis (Thrombus) 12/2020 - 01/2012
5	Cognitive Dysfunction 01/2019 - 11/2010
5	Reperfusion Injury 01/2019 - 03/2009
5	Flatulence 09/2017 - 10/2011
4	Spinal Cord Injuries (Spinal Cord Injury) 01/2023 - 08/2014

Drug/Important Bio-Agent (IBA)

51	Proteins (Proteins, Gene)FDA Link 10/2022 - 04/2004
32	MicroRNAs (MicroRNA)IBA 06/2022 - 08/2008
32	Biomarkers (Surrogate Marker)IBA 05/2022 - 11/2011
23	Pharmaceutical PreparationsIBA 08/2022 - 05/2004
21	CollagenIBA 01/2022 - 03/2011
21	Messenger RNA (mRNA)IBA 01/2022 - 02/2002
19	Biological ProductsIBA 06/2022 - 11/2009
19	Long Noncoding RNAIBA 01/2022 - 04/2014
14	CytokinesIBA 05/2022 - 11/2009
12	DNA (Deoxyribonucleic Acid)IBA 10/2022 - 04/2005
11	Peptides (Polypeptides)IBA 12/2021 - 05/2003
10	Small Interfering RNA (siRNA)IBA 12/2020 - 08/2005
9	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2023 - 01/2014
9	VaccinesIBA 01/2021 - 03/2002
8	Interleukin-6 (Interleukin 6)IBA 09/2022 - 08/2014
8	Glucose (Dextrose)FDA LinkGeneric 08/2022 - 03/2012
8	Therapeutic UsesIBA 01/2022 - 01/2016
8	SteroidsIBA 01/2022 - 09/2003
8	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021 - 08/2005
8	nephrinIBA 01/2014 - 11/2003
7	RNA (Ribonucleic Acid)IBA 10/2022 - 04/2005
7	Estrogen ReceptorsIBA 03/2022 - 03/2014
7	Phosphotransferases (Kinase)IBA 01/2022 - 08/2013
7	Complement System Proteins (Complement)IBA 01/2022 - 10/2010
7	CreatinineIBA 01/2019 - 03/2012
7	NPHS2 proteinIBA 12/2017 - 11/2003
6	CholesterolIBA 10/2022 - 01/2019
6	Immunoglobulin G (IgG)IBA 06/2022 - 01/2019
6	EnzymesIBA 01/2022 - 03/2009
6	LigandsIBA 01/2022 - 01/2012
6	DecorinIBA 01/2021 - 05/2011
6	Retinaldehyde (Retinal)IBA 01/2021 - 11/2010
6	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2020 - 07/2005
6	Collagen Type IV (Type IV Collagen)IBA 01/2020 - 04/2005
6	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2020 - 03/2014
6	AntigensIBA 11/2017 - 05/2003
5	LipopolysaccharidesIBA 10/2022 - 05/2011
5	Hormones (Hormone)IBA 08/2022 - 01/2019
5	68Ga-pentixaforIBA 08/2022 - 01/2019
5	Untranslated RNA (Noncoding RNA)IBA 06/2022 - 06/2014
5	salicylhydroxamic acid (SHAM)IBA 06/2022 - 01/2012
5	LipidsIBA 04/2022 - 08/2010
5	cyanoginosin LR (microcystin LR)IBA 04/2022 - 01/2019
5	ChemokinesIBA 01/2022 - 10/2010
5	Protein Isoforms (Isoforms)IBA 01/2022 - 09/2008
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 01/2012
5	Transcription Factors (Transcription Factor)IBA 01/2021 - 07/2011
5	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2021 - 05/2011
5	erucylphosphocholineIBA 12/2019 - 02/2015
5	Puromycin AminonucleosideIBA 01/2016 - 04/2004
5	melamineIBA 11/2011 - 03/2009
4	HydrogelsIBA 01/2023 - 12/2020

Therapy/Procedure

66	Therapeutics 08/2022 - 05/2004
17	Drug Therapy (Chemotherapy) 08/2022 - 01/2006
9	Transplantation 01/2020 - 03/2011
8	Immunotherapy 01/2022 - 01/2009
7	Length of Stay 01/2021 - 10/2011
5	Lasers (Laser) 08/2022 - 11/2012
5	Ligation 11/2021 - 06/2009